ASPEN PHARMACARE HOLDINGS LIMITED - Conclusion of arrangements in respect of acquisition finance facilities

Conclusion of arrangements in respect of acquisition finance facilities

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
("Aspen" or "the Company")


CONCLUSION OF ARRANGEMENTS IN RESPECT OF ACQUISITION FINANCE
FACILITIES OF US$1,985,000,000 AND ZAR 7,330,000,000

With reference to the announcement to Aspen’s shareholders made on
13 September 2013, Aspen is pleased to confirm that Bank of America
Merrill Lynch and The Standard Bank of South Africa Limited (together
the “Initial Mandated Lead Arrangers and Bookrunners”) have
successfully closed the syndication of the US$1,985,000,000
acquisition finance facilities for Aspen Global Incorporated (“AGI”) a
100% owned subsidiary of Aspen and that this syndication was fully
subscribed. Shareholders are also advised that the initial syndication
amount of US$2,035,000,000 has been reduced to US$1,985,000,000 due to
reduced funding requirements.

The facilities which were partially underwritten by the Initial
Mandated Lead Arrangers will be used to (i) support current and
prospective acquisitions being undertaken by AGI; and (ii) refinance
all of AGI’s existing term bank debt.

The Facilities

The summary terms of the AGI facilities are as follows:

                                                            Currency
                                                  Initial
 Facility                Amount          Tenor              of
                                                  Margin
                                                            Commitment

 Term Loan Facility A    US$705,000,000 3 years   240 bps   USD


 Amortising Term Loan
                         US$705,000,000 5 years   250 bps   USD
 Facility B


 Term Loan Facility C1   US$237,500,000 3 years   240 bps   USD


 Amortising
                         US$237,500,000 5 years   250 bps   USD
 Term Loan Facility C2

With respect to the syndication of the ZAR 7,330,000,000 facilities
for Pharmacare (a 100% owned subsidiary of Aspen) and Aspen, it is
confirmed that commitments have been received, and that the
syndication has been successfully closed, with significant support
from the local ZAR banking and institutional market.

For any further enquiries in this regard please contact:
Hymie Shapiro
Group Financial Executive
Aspen Pharmacare Holdings Limited
Tel:    +27 11 239 6124
Email: shapiroh@aspenpharma.com



Durban
24 October 2013

Underwriters
Bank of America, N.A.
The Standard Bank of South Africa Limited

Mandated Lead Arrangers and Bookrunners
Banc of America Securities Limited
The Standard Bank of South Africa Limited

Sponsor
Investec Bank Limited

Date: 24/10/2013 05:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.